Y5W-32122-31327
2 vaccinations
5 coded responses
19 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 211 / MD
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Survey response — day 0, dose 1MedDRA: Fatigue, Injection site pain — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: The pain at the site and fatigue are more than mild but not limiting my daily activities. My range of motion is limited so I am not doing my normal workout and some tasks will be difficult.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Ear pruritus, Lacrimation increased, Paranasal sinus discomfort, Rhinorrhoea — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Sinus pressure, ear pressure, mild sniffles and watery eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-16
- 2021-01-17
- 2021-01-18
-
2021-02-04
Dose 2 — Pfizer-BioNTech
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Ear discomfort, Ear pain, Nasal congestion, Neck pain — Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Pressure and pain in the ear and pain in neck on injection side, stuffy noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Discomfort, Ear discomfort, Lacrimation increased, Musculoskeletal discomfort, Musculoskeletal stiffness, Oedema peripheral, Pruritus, Respiratory tract congestion — Feeling: Fair · Site: Pain, Swelling · Muscle or body achesFree text: Stiffness, discomfort in the neck and shoulder on injection side,itching and discomfort around underarm, watery eyes, mild stuffiness, ear pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-08
- 2021-02-09
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Eye irritation, Lacrimation increased, Periorbital swelling — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Eye is irritated and puffy, wateringMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-20
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-08
- 2021-08-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-14 | priority 2/3 |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): The pain at the site and fatigue are more than mild but not limiting my daily activities. My range of motion is limited so I am not doing my normal workout and some tasks will be difficult.
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Sinus pressure, ear pressure, mild sniffles and watery eyes
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Pressure and pain in the ear and pain in neck on injection side, stuffy nose
Systemic reaction (other): Stiffness, discomfort in the neck and shoulder on injection side,itching and discomfort around underarm, watery eyes, mild stuffiness, ear pressure
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Eye is irritated and puffy, watering
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Discomfort | ✓ | · | ✓ |
| SRO | Ear discomfort | ✓ | ✓ | ✓ |
| SRO | Ear pain | ✓ | ✓ | ✓ |
| SRO | Ear pruritus | ✓ | ✓ | ✓ |
| SRO | Eye irritation | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Lacrimation increased | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal discomfort | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ○ | ✓ | ○ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SRO | Periorbital swelling | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release